Bidirectional information sharing between Nagoya Memorial Hospital and health insurance pharmacies using a communication sheet for pharmaceutical cooperation
暂无分享,去创建一个
S. Yuasa | S. Hibi | K. Ina | Megumi Kabeya | S. Kayukawa
[1] D. Rischin,et al. A systematic review of the impact of outpatient clinical pharmacy services on medication-related outcomes in patients receiving anticancer therapies , 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[2] C. Campen,et al. Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting. , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[3] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[4] Cathal A. Cadogan,et al. Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review , 2016, Drugs & Aging.
[5] S. Yuasa,et al. [Cooperation between a Hospital without Dentists and Local Dental Associations in Oral Management of Cancer Patients]. , 2015, Gan to kagaku ryoho. Cancer & chemotherapy.
[6] M. Fitch,et al. Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. , 2014 .
[7] Kogenta Nakamura,et al. Management of adverse events in patients with metastatic renal cell carcinoma treated with sunitinib and clinical outcomes. , 2013, Anticancer research.
[8] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[9] J. D. de Gier,et al. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. , 2012, British journal of clinical pharmacology.
[10] J. Lees,et al. Polypharmacy in elderly patients with cancer: clinical implications and management. , 2011, The Lancet. Oncology.
[11] T. Sagar,et al. Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia , 2011, American journal of hematology.
[12] D. L. Smith,et al. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[13] K. Rezvani,et al. Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. , 2010, Blood.
[14] T. Morita,et al. Role of the community pharmacy in palliative care: a nationwide survey in Japan. , 2010, Journal of palliative medicine.
[15] L. Chew,et al. Evolving roles of oncology pharmacists in Singapore: A survey on prescribing patterns of antiemetics for chemotherapy induced nausea and vomiting (CINV) at a cancer centre† , 2008, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[16] H. Uramoto,et al. Evaluation of the quality of life between inpatients and outpatients receiving cancer chemotherapy in Japan. , 2007, Anticancer research.
[17] J. Atkins,et al. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5‐hydroxytryptamine‐3 antiemetics , 2003, Cancer.
[18] K. Ina,et al. Trial of Seamless Regional Cooperation in Palliative Care of Cancer Patients Using Communication Tools of Cooperation , 2018 .
[19] S. Yuasa,et al. Communication Form of Cooperation between Hospitals and Health Insurance Pharmacies Designed Based on the Results of a Questionnaire Survey on Cancer Patients and Community Pharmacists , 2015 .
[20] A. Wakita,et al. Survey on the Use of Chemotherapy Labels and Regimen Worksheets to Provision of Information for Community Pharmacies , 2015 .
[21] H. Araki,et al. Evaluation of Bidirectional Sharing of Patient Information for S-1 between Hospitals and Community Pharmacies using a Modified Prescription Format , 2014 .
[22] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[23] J. Verweij,et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. , 1997, British Journal of Cancer.